EP2863906

USE OF FERRIC CITRATE IN THE TREATMENT OF CHRONIC KIDNEY DISEASE PATIENTS

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    21.6.2013
  • EP published:
    18.3.2020
  • EP application number:
    13807102.2
  • Max expiry date:
    20.6.2033
  • Title:
    USE OF FERRIC CITRATE IN THE TREATMENT OF CHRONIC KIDNEY DISEASE PATIENTS

Timeline

Today
21.6.2013EP application
18.3.2020EP Publication

Owner

  • Name:
    Keryx Biopharmaceuticals, Inc.
  • Address:
    245 First Street, Suite 1400, Cambridge, MA 02142, US

Inventor

  • Name:
    PORADOSU, Enrique
  • Address:
    Brookline, Massachusetts 02446, US
  • Name:
    BENTSUR, Ron
  • Address:
    Tenafly, New Jersey 07670, US
  • Name:
    OLIVIERO III, James F.
  • Address:
    New York, NY 10013, US

Priority

  • Number:
    201261662565 P
  • Date:
    21.6.2012
  • Country:
    US
  • Number:
    201361757229 P
  • Date:
    28.1.2013
  • Country:
    US
  • Number:
    201361801050 P
  • Date:
    15.3.2013
  • Country:
    US
  • Number:
    201361800618 P
  • Date:
    15.3.2013
  • Country:
    US

Classification

  • Categories:
    A61K 31/295, A61P 7/06, A61P 13/12, A61K 9/28

Upload documents